iomeron 200 mg/ml solution for injection
bracco imaging s.p.a. - iomeprol - 200 mg/ml solution for injection
iomeron 250 mg/ml solution for injection
bracco imaging s.p.a. - iomeprol - 250 mg/ml solution for injection
iomeron 300 mg/ml solution for injection
bracco imaging s.p.a. - iomeprol - 300 mg/ml solution for injection
iomeron 350 mg/ml solution for injection
bracco imaging s.p.a. - iomeprol - 350 mg/ml solution for injection
iomeron 400 mg/ml solution for injection
bracco imaging s.p.a. - iomeprol - 400 mg/ml solution for injection
iopamiro 300 mg/ml solution for injection
bracco imaging s.p.a. - iopamidol - 300 mg/ml solution for injection
iopamiro 370 mg/ml solution for injection
bracco imaging s.p.a. - iopamidol - 370 mg/ml solution for injection
ximluci
stada arzneimittel ag - ранимизумаб - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Офталмологични - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
resolor
takeda pharmaceuticals international ag ireland - Сукцинат prucalopride - запек - Други лекарства за запек - resolor е показан за симптоматично лечение на хроничен констипация при възрастни, при които лаксативите не осигуряват адекватно облекчение.
byooviz
samsung bioepis nl b.v. - ранимизумаб - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - Офталмологични - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).